Global Cancer/Tumor Profiling Market Report By Application (Clinical Applications, And Research Applications), Technology (Immunoassays, Hybridization, Next-Generation Sequencing, Mass Spectroscopy, And Other Technologies (Pyrosequencing And Sanger Sequencing)), Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, And Other Cancer Types) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210449
February 2019
Report Formats:

As per this study, the Global Cancer/Tumor Profiling Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Cancer/Tumor profiling is a technique intends to get knowledge about cancer profile and genomic alteration of a patient, which can offer useful insights related to the mechanism of cancer. Basically, this technique assists physicians to opt appropriate therapy, and at the same time eliminates the therapies, which are doubtful and avoid over-treatment of the patient. In addition, cancer profiling is not limited to common cancer such as breast cancer and lymphoma, but it is also useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia.
 
Market Dynamics
 
The growing number of cancer cases across the globe is the major factor driving the demand for cancer/tumor profiling. The increasing utility of biomarkers and funding for cancer research is further fuelling the market growth. In addition to this, efficient and effective result of this profiling is also boosting the market growth. However, high cost associated with the diagnosis and usage of these methods for the treatment may hamper the market growth.  Whereas, the rising need for point-of-care diagnostics and personalized medicines is expected to offer new opportunities growth to the market growth over the forecast period.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of cancer/tumor profiling.
 
Market Segmentation
 
The broad cancer/tumor profiling market has been sub-grouped into the application, technology and cancer type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Application

  • Clinical Applications
  • Research Applications
 
By Technology
  • Immunoassays
  • Hybridization
  • Next-generation Sequencing
  • Mass Spectroscopy
  • Other Technologies (Pyrosequencing and Sanger Sequencing)
 
By Cancer Type
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Other Cancer Types
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for cancer/tumor profiling in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Cancer/Tumor Profiling Market By Revenue (USD MN)
 
Europe Cancer/Tumor Profiling Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the cancer/tumor profiling market include Claris Life Sciences, Personal Genome Diagnostics, Inc., Perthera, Inc., Foundation Medicine, Inc. V., Strand, ApoCell, Contextual Genomics, Agendia, and GenScript. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Cancer/Tumor Profiling
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Cancer/Tumor Profiling Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. CANCER/TUMOR PROFILING MARKET ANALYSIS BY APPLICATION
  • Market In Clinical Applications
  • Market In Research Applications
 
5. CANCER/TUMOR PROFILING MARKET ANALYSIS BY TECHNOLOGY
  • Market In Immunoassays
  • Market In Hybridization
  • Market In Next-Generation Sequencing
  • Market In Mass Spectroscopy
  • Market In Other Technologies (Pyrosequencing And Sanger Sequencing)
 
6. CANCER/TUMOR PROFILING MARKET ANALYSIS BY CANCER TYPE
  • Market In Breast Cancer
  • Market In Lung Cancer
  • Market In Colorectal Cancer
  • Market In Prostate Cancer
  • Market In Melanoma Cancer
  • Market In Other Cancer Types
 
7. CANCER/TUMOR PROFILING MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
8. COMPETITIVE LANDSCAPE OF THE CANCER/TUMOR PROFILING COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
9. COMPANY PROFILES OF THE CANCER/TUMOR PROFILING INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Agendia
  • ApoCell
  • Claris Life Sciences
  • Contextual Genomics
  • Foundation Medicine, Inc. V.
  • GenScript
  • Personal Genome Diagnostics, Inc.
  • Perthera, Inc.
  • Strand
 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Cancer/Tumor Profiling
Table 2.  Global Cancer/Tumor Profiling Market By Application
Table 3.  Global Cancer/Tumor Profiling Market By Technology
Table 4.  Global Cancer/Tumor Profiling Market By Cancer Type
Table 5.  Global Cancer/Tumor Profiling Market By Geography
Table 6.  North America Cancer/Tumor Profiling Market
Table 7.  Europe Cancer/Tumor Profiling Market
Table 8.  Asia Pacific Cancer/Tumor Profiling Market
Table 9.  Latin America Cancer/Tumor Profiling Market
Table 10. Middle East And Africa Cancer/Tumor Profiling Market 
Table 11. Partnership/Collaboration/Agreements
Table 12. Mergers And Acquisitions
Table 13. New Product Development
Table 14. Other Developments
 
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Cancer/Tumor Profiling Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Cancer/Tumor Profiling
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Cancer/Tumor Profiling Market By Application
Fig. 8.     Global Cancer/Tumor Profiling Market By Technology
Fig. 9.     Global Cancer/Tumor Profiling Market By Cancer Type
Fig. 10.   Global Cancer/Tumor Profiling Market By Geography
Fig. 11.   North America Cancer/Tumor Profiling Market
Fig. 12.   Europe Cancer/Tumor Profiling Market
Fig. 13.   Asia Pacific Cancer/Tumor Profiling Market
Fig. 14.   Latin America Cancer/Tumor Profiling Market
Fig. 15.   Middle East And Africa Cancer/Tumor Profiling Market
Fig. 16.   Market Share Of Cancer/Tumor Profiling Companies
Fig. 17.   Recent Developments In Cancer/Tumor Profiling Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials